Brace Yourselves: A Major 340B Hospital Court Ruling and CMS Proposed Rule Are Coming


A note from Publisher and CEO Ted Slafsky: Happy Tuesday! I hope all is well with everyone and you get to enjoy the upcoming holiday. Our sponsors are 340B’s industry leaders and we are proud to

Read More »

Hospitals Might Not Get 340B Discounts on Drugs Being Investigated as COVID-19 Treatments


A note from Publisher and CEO Ted Slafsky: Please join us in welcoming FQHC 340B to our growing list of 340B Report sponsors. We look forward to partnering with them and having our readers learn

Read More »

House Bipartisan Bills Address Worries About COVID-19 Drug Price Gouging


A Message from Publisher and CEO Ted Slafsky:  Not only has the COVID-19 pandemic taken an enormous toll on health care workers, it has also been a major hit to 340B covered entities’ finances. I encourage

Read More »

MedPAC Report Endnote Sheds Light on Hospital Losses Due to CMS 340B Drug Payment Cuts


Happy Juneteenth from Publisher and CEO Ted Slafsky: Our sponsors are 340B’s industry leaders and we are proud to showcase their innovative solutions and guidance to help you implement and comply with this complex program. Benefits

Read More »

340B Drug Manufacturer Audits: A Q&A with HRSA


A note from 340B Report CEO and Publisher Ted Slafsky: Please join us in welcoming Comprehensive Pharmacy Services to our growing group of 340B Report sponsors! And I hope you enjoy a new column from

Read More »

HRSA Takes Step to Improve 340B Pricing Consistency


A note from 340B Report CEO and Publisher Ted Slafsky: I encourage all of you to read Trellis Rx Chief Pharmacy Officer Jerry Buller’s great article in today’s issue about how 340B health systems can leverage

Read More »

340B Experts Welcome HRSA’s Policy Clarifications on Hospital Child Sites and Telemedicine


Happy Thursday from Publisher and CEO Ted Slafsky: Our sponsors are 340B’s industry leaders and we are proud to showcase their innovative solutions and guidance to help you implement and comply with this complex program. Benefits

Read More »

EXCLUSIVE: HRSA Confirms 340B Hospital Offsite Location and Telehealth Flexibilities Are Permanent


Happy Tuesday from Publisher and CEO Ted Slafsky: In today’s issue, you will see a great piece on a little covered but important topic regarding the rights that covered entities have to resolve disputes with pharmaceutical

Read More »

Breaking News

BREAKING: HRSA Moves Forward on Plan To Allow for Expedited 340B Hospital Clinic Enrollment

SPONSORED BY

Read More »

HRSA Lifts Major Barrier to Using 340B Drugs at Hospital Offsite Locations


Happy Thursday from Publisher and CEO Ted Slafsky: Our sponsors are 340B’s industry leaders and we are proud to showcase their innovative solutions and guidance to help you implement and comply with this complex program. In

Read More »